Choosing the right fillers: we calculate the expected effect

For the correction of age-related changes in the face, the most popular among patients is contour plastic surgery, which is carried out with the help of injectable fillers. It makes it possible to achieve results that are quite comparable with the success of surgical intervention, but at the same time it attracts with its minimally invasiveness. In order for the face correction to be successful and to please the patient with exactly the results that he expected, the doctor must choose the fillers that are most suitable for a particular situation. A good choice of fillers with different properties is provided by the Neuramis line from the company Emet^TM. For more information about which drug is better to choose and what the expected effect will be, read on estet-portal.com.

Which principle to choose fillers: the importance of production technologies

The most popular preparations for facial contouring are fillers of various densities based on stabilized hyaluronic acid. In order to successfully choose fillers, you need to remember that the drugs must meet several important criteria:

• safety for the patient;

• no allergic reactions to the drug;

• sustainability and effectiveness of results;

• minimization of side effects after administration;

• low pain on injection.

You should also pay attention to such characteristics of the filler as cohesiveness, viscosity, elasticity, uniformity of distribution and rate of biodegradation.

Neuramis fillers from the South Korean international research biopharmaceutical company Medytox, presented on our market by Emet^TM

, have become the drugs of choice for many cosmetologists.

Neuramis products are monophasic fillers based on hyaluronic acid. Hyaluronic acid for the production of Neuramis fillers is supplied by the Shiseido factory. and approved by FDA. They have the same concentration of hyaluronate – 20 mg/ml, but with varying degrees of stabilization of its molecules. Hyaluronic acid in Neuramis fillers is stabilized and purified using the unique SHAPE technology, patented by the South Korean international research and development biopharmaceutical company Medytox. The essence of the stabilization technology is the two-stage formation of cross-links, specific for each filler. Cleaning of finished products also takes place in two stages: the drug is cleared of unbound hyaluronic acid and molecules, coupled at one end, as well as cleaning of residual unused crosslinks BDDE. This approach provides good indicators of cohesiveness, as well as indicators of viscoelasticity of the filler. Due to these properties, the filler is evenly and naturally distributed in various tissues of the face and does not lose its shape under mechanical pressure on the surrounding tissues. Biodegradation of fillers occurs evenly and during the stated period of stay in the tissues, in addition, the risks of fragmentation are excluded. The control of the absence of residual protein, unused BDDE crosslinks and unbound hyaluronic acid molecules ensures the absence of edema, cytotoxic and allergic reactions during the procedure and the post-injection period.

and cleaning of residual unused crosslinks

BDDE

.

This approach provides good

cohesiveness as well as

viscoelasticity of the filler. Due to these properties, the filler is evenly and naturally distributed in various tissues of the face and does not lose its shape under mechanical pressure on the surrounding tissues. Biodegradation of fillers occurs evenly and during the stated period of stay in the tissues, in addition, the risks of fragmentation are excluded. The control of the absence of residual protein, unused BDDE crosslinks and unbound hyaluronic acid molecules ensures the absence of edema, cytotoxic and allergic reactions during the procedure and the post-injection period. and cleaning of residual unused crosslinks BDDE.This approach provides good cohesiveness as well as viscoelasticity of the filler. Due to these properties, the filler is evenly and naturally distributed in various tissues of the face and does not lose its shape under mechanical pressure on the surrounding tissues. Biodegradation of fillers occurs evenly and during the stated period of stay in the tissues, in addition, the risks of fragmentation are excluded. The control of the absence of residual protein, unused BDDE crosslinks and unbound hyaluronic acid molecules ensures the absence of edema, cytotoxic and allergic reactions during the procedure and the post-injection period.How to navigate the variety and choose the right fillersMedicine nameSpecial FeaturesPurposeNeuramis Mesoviscoelastic gel of unstabilized hyaluronic acid, mannitol. Biorevitalizantdesigned to restore skin hydrobalance, improve skin structure and skin elasticity.Neuramis Light LidocaineNeuramis Lidocaine

In order to choose the best drug that best suits a particular patient, you need to know the features of specific fillers and their functionality. The palette of Neuramis fillers consists of 6 positions, each of the drugs has its own purpose. Some of them moisturize and smooth the skin, others restore the dermal framework, there are positions that replenish the lost volume of deep facial fat packages. Neuramis fillers can be selected very accurately for contouring each third of the face, and on different layers. Features of Neuramis fillers
Hyaluronic acid stabilized gel. Has the lowest degree of binding	designed for prolonged biorevitalization, correction of fine wrinkles, long-term restoration of skin hydrobalance, improvement of skin structure and elasticity.
stabilized hyaluronic acid gel with lidocaine	Designed to correct fine and moderate wrinkles, slight increase in lip volume, "kissed lips" effect.
Neuramis Deep and Neuramis Deep Lidocaine	Varieties of "universal" filler – with and without lidocaine	Correction of moderate and deep wrinkles, nasolabial folds, sometimes nasolacrimal sulcus, significant increase in lip volume, nose contouring

Neuramis Volume Lidocaine Highest density, deep periosteal placement, contains lidocaine

Correction of deep wrinkles and folds, restoration of lost volumes in the area of ​​cheekbones and chin shape, correction of facial contours

Most Neuramis preparations contain 0.3% lidocaine in their composition, which allows for injections with minimal discomfort for the patient and this, of course, increases his adherence to corrective procedures. Fillers do not give puffiness in the rehabilitation period. Clinical studies have confirmed the effectiveness and good tolerance of Neuramis fillers as preparations for remodeling the contours and volumes of the cheekbones, reducing the severity of nasolabial folds, and correcting the shape and volume of the lips. Using Neyramis fillers, you can be sure that the volume received during the procedure will remain for the stated guaranteed time. An additional bonus of this line of fillers is that each position contains two ultra-fine needles manufactured by TSK. Thus, the correct choice of Neuramis fillers from the company EmetTM ensures the safety and effectiveness of corrective procedures, and allows you to achieve the expected result.